Over 12 months, Pelthos Therapeutics Inc. saw more buying than selling from its insiders — purchases of about $1,000,000 against sales of $486,000.
Biggest single buyer: Davis Todd C, Director, with roughly $985,000.
On the institutional side, 24 funds reported holding PTHS at the end of Q2 2026, and more funds bought than sold. Last full quarter: net selling by insiders. Insiders bought in 1 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | Friedberg Ezra M | Director | Sell | 558 | $20.72 | $12K | SEC |
| Oct 6, 2026 | Pauls Matthew | Director | Sell | 786 | $21.00 | $17K | SEC |
| Oct 6, 2026 | Greenleaf Peter | Director | Sell | 797 | $21.17 | $17K | SEC |
| Jul 7, 2026 | Friedberg Ezra M | Director | Sell | 534 | $26.03 | $14K | SEC |
| Jul 7, 2026 | Friedberg Ezra M | Director | Sell | 24 | $27.33 | $656 | SEC |
| Jul 7, 2026 | Pauls Matthew | Director | Sell | 94 | $27.36 | $3K | SEC |
| Jul 7, 2026 | Pauls Matthew | Director | Sell | 692 | $26.00 | $18K | SEC |
| Jul 7, 2026 | Greenleaf Peter | Director | Sell | 712 | $26.00 | $19K | SEC |
| Jul 7, 2026 | Greenleaf Peter | Director | Sell | 85 | $27.27 | $2K | SEC |
| Jun 17, 2026 | Friedberg Ezra M | Director | Sell | 224 | $27.12 | $6K | SEC |
| Jun 17, 2026 | Friedberg Ezra M | Director | Sell | 59 | $27.94 | $2K | SEC |
| Jun 15, 2026 | Davis Todd C | Director | Buy | 503 | $28.73 | $14K | SEC |
| Jun 15, 2026 | Davis Todd C | Director | Buy | 35,445 | $27.80 | $985K | SEC |
| May 26, 2026 | Francis Knuettel II | CFO | Sell | 1,500 | $26.84 | $40K | SEC |
| Apr 6, 2026 | Friedberg Ezra M | Director | Sell | 293 | $20.51 | $6K | SEC |
In the last 12 months Pelthos Therapeutics Inc. insiders made open-market purchases worth about $1,000,000 and sales worth about $486,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in PTHS was filed on 2026-10-06.
24 investment managers reported holding PTHS in SEC Form 13F filings for Q2 2026.
No congressional trades in PTHS were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).